Literature DB >> 12664136

Imaging of dihydrofolate reductase fusion gene expression in xenografts of human liver metastases of colorectal cancer in living rats.

Philipp Mayer-Kuckuk1, Mikhail Doubrovin, Niraj J Gusani, Terence Gade, Julius Balatoni, Tim Akhurst, Ronald Finn, Yuman Fong, Jason A Koutcher, Steven Larson, Ronald Blasberg, Juri Gelovani Tjuvajev, Joseph R Bertino, Debabrata Banerjee.   

Abstract

Radionuclide imaging has been demonstrated to be feasible to monitor transgene expression in vivo. We hypothesized that a potential application of this technique is to non-invasively detect in deep tissue, such as cancer cells metastatic to the liver, a specific molecular response following systemic drug treatment. Utilizing human colon adenocarcinoma cells derived from a patient's liver lesion we first developed a nude rat xenograft model for colorectal cancer metastatic to the liver. Expression of a dihydrofolate reductase-herpes simplex virus 1 thymidine kinase fusion (DHFR-HSV1 TK) transgene in the hepatic tumors was monitored in individual animals using the tracer [(124)I]2'-fluoro-2'-deoxy-5-iodouracil-beta- d-arabinofuranoside (FIAU) and a small animal micro positron emission tomograph (microPET), while groups of rats were imaged using the tracer [(131)I]FIAU and a clinical gamma camera. Growth of the human metastatic colorectal cancer cells in the rat liver was detected using magnetic resonance imaging and confirmed by surgical inspection. Single as well as multiple lesions of different sizes and sites were observed in the liver of the animals. Next, using a subset of rats bearing hepatic tumors, which were retrovirally bulk transduced to express the DHFR-HSV1 TK transgene, we imaged the fusion protein expression in the hepatic tumor of living rats using the tracer [(124)I]FIAU and a microPET. The observed deep tissue signals were highly specific for the tumors expressing the DHFR-HSV1 TK fusion protein compared with parental untransduced tumors and other tissues as determined by gamma counting of tissue samples. A subsequent study used the tracer [(131)I]FIAU and a gamma camera to monitor two groups of transduced hepatic tumor-bearing rats. Prior to imaging, one group was treated with trimetrexate to exploit DHFR-mediated upregulation of the fusion gene product. Imaging in the living animal as well as subsequent gamma counting of tissue samples showed increased signal and tracer accumulation, respectively, as compared to the group not treated with the antifolate. It is concluded that the two examined nucleotide imaging methods are feasible techniques for monitoring of DHFR-HSV TK fusion protein expression in hepatic colorectal tumor tissue in living animals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12664136     DOI: 10.1007/s00259-003-1143-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  31 in total

Review 1.  Molecular imaging.

Authors:  R Weissleder; U Mahmood
Journal:  Radiology       Date:  2001-05       Impact factor: 11.105

2.  Characterization and drug sensitivity of four newly established colon adenocarcinoma cell lines to antifolate inhibitors of thymidylate synthase.

Authors:  G S Longo; J Izzo; R Gorlick; D Banerjee; S C Jhanwar; J R Bertino
Journal:  Oncol Res       Date:  2001       Impact factor: 5.574

3.  Phase I study of direct administration of a replication deficient adenovirus vector containing the E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the pro-drug 5-fluorocytosine.

Authors:  R G Crystal; E Hirschowitz; M Lieberman; J Daly; E Kazam; C Henschke; D Yankelevitz; N Kemeny; R Silverstein; A Ohwada; T Russi; A Mastrangeli; A Sanders; J Cooke; B G Harvey
Journal:  Hum Gene Ther       Date:  1997-05-20       Impact factor: 5.695

4.  Increased expression of sialyl-dimeric LeX antigen in liver metastases of human colorectal carcinoma.

Authors:  S D Hoff; Y Matsushita; D M Ota; K R Cleary; T Yamori; S Hakomori; T Irimura
Journal:  Cancer Res       Date:  1989-12-15       Impact factor: 12.701

5.  Adenoviral gene transfer of interleukin 12 into tumors synergizes with adoptive T cell therapy both at the induction and effector level.

Authors:  G Mazzolini; C Qian; I Narvaiza; M Barajas; F Borrás-Cuesta; X Xie; M Duarte; I Melero; J Prieto
Journal:  Hum Gene Ther       Date:  2000-01-01       Impact factor: 5.695

6.  Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo.

Authors:  J G Tjuvajev; S H Chen; A Joshi; R Joshi; Z S Guo; J Balatoni; D Ballon; J Koutcher; R Finn; S L Woo; R G Blasberg
Journal:  Cancer Res       Date:  1999-10-15       Impact factor: 12.701

7.  Cells exposed to antifolates show increased cellular levels of proteins fused to dihydrofolate reductase: a method to modulate gene expression.

Authors:  Philipp Mayer-Kuckuk; Debabrata Banerjee; Sundeep Malhotra; Mikhail Doubrovin; Marian Iwamoto; Tim Akhurst; Julius Balatoni; William Bornmann; Ronald Finn; Steven Larson; Yuman Fong; Juri Gelovani Tjuvajev; Ronald Blasberg; Joseph R Bertino
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

8.  Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression.

Authors:  Juri Gelovani Tjuvajev; Mikhail Doubrovin; Timothy Akhurst; Shangde Cai; Julius Balatoni; Mian M Alauddin; Ronald Finn; William Bornmann; Howard Thaler; Peter S Conti; Ronald G Blasberg
Journal:  J Nucl Med       Date:  2002-08       Impact factor: 10.057

9.  Tumour uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models. IX. Radiolabelled 1-(2'-fluoro-2'-deoxy-beta-D-ribofuranosyl)uracil and 1-(2'-chloro-2'-deoxy-beta-D-ribofuranosyl)uracil.

Authors:  D N Abrams; Y W Lee; J R Mercer; E E Knaus; L I Wiebe
Journal:  Br J Radiol       Date:  1986-03       Impact factor: 3.039

10.  The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer model.

Authors:  M K Nyati; Z Symon; E Kievit; K J Dornfeld; S D Rynkiewicz; B D Ross; A Rehemtulla; T S Lawrence
Journal:  Gene Ther       Date:  2002-07       Impact factor: 5.250

View more
  1 in total

1.  Measurements of T1 and T2 relaxation times of colon cancer metastases in rat liver at 7 T.

Authors:  G Gambarota; A Veltien; H van Laarhoven; M Philippens; A Jonker; O R Mook; W M Frederiks; A Heerschap
Journal:  MAGMA       Date:  2004-12-01       Impact factor: 2.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.